EUVIMEDEUVIMED entdecken
Crossref

Different formulations of semaglutide and oxidative stress in subjects with type 2 diabetes and MASLD: an open-label, real-life study

Giovanni Petralli, Alice Del Zoppo, Chiara Rovera, Francesco Raggi, Antonio Salvati, Diego Moriconi, Mariarosaria Distaso, Maurizia Rossana Brunetto, Anna Solini

Acta Diabetologica · 2025

DOI: 10.1007/s00592-025-02466-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Diabetologica, 2025. Verfasst von Giovanni Petralli und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Medical, Molecular and Critical Area Pathology, University of Pisa, Pisa, Italy. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Oxidative Stress, Glucagon-Like Peptides, Hypoglycemic Agents. Die Arbeit nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Oxidative StressGlucagon-Like PeptidesHypoglycemic AgentsFatty LiverHumansMaleFemaleMiddle AgedProspective StudiesAgedAdultAdministration, OralGlucagon-Like Peptide 1Semaglutide

Stichwörter der Autor:innen

Injective semaglutideMASLDOral semaglutideOxidative stress

Substanzen

Glucagon-Like PeptidesHypoglycemic AgentsGlucagon-Like Peptide 1Semaglutide

Autor:innen und Institutionen

  • Department of Surgical Medical, Molecular and Critical Area Pathology, University of Pisa, Pisa, Italy.
  • Hepatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
  • Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Department of Surgical Medical, Molecular and Critical Area Pathology, University of Pisa, Pisa, Italy. anna.solini@unipi.it.
  • Department of Surgical Medical Molecular and Critical Area Pathology, University of Pisa, Via Roma 67, Pisa, 56126, Italy. anna.solini@unipi.it.

Zitieren

APA

Petralli, G., Zoppo, A. D., Rovera, C., Raggi, F., Salvati, A., Moriconi, D., Distaso, M., Brunetto, M. R., & Solini, A. (2025). Different formulations of semaglutide and oxidative stress in subjects with type 2 diabetes and MASLD: an open-label, real-life study. Acta Diabetologica. https://doi.org/10.1007/s00592-025-02466-7

Vancouver

Petralli G, Zoppo AD, Rovera C, Raggi F, Salvati A, Moriconi D, et al. Different formulations of semaglutide and oxidative stress in subjects with type 2 diabetes and MASLD: an open-label, real-life study. Acta Diabetologica. 2025. doi:10.1007/s00592-025-02466-7

BibTeX
@article{Petralli2025,
  author = {Petralli, Giovanni and Zoppo, Alice Del and Rovera, Chiara and Raggi, Francesco and Salvati, Antonio and Moriconi, Diego and Distaso, Mariarosaria and Brunetto, Maurizia Rossana and Solini, Anna},
  title = {Different formulations of semaglutide and oxidative stress in subjects with type 2 diabetes and MASLD: an open-label, real-life study},
  journal = {Acta Diabetologica},
  year = {2025},
  doi = {10.1007/s00592-025-02466-7}
}
Kostenlos starten →